Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.91
Delayed Data
As of Jun 27
 -0.16 / -0.36%
Today’s Change
37.20
Today|||52-Week Range
45.58
+14.02%
Year-to-Date
Top Analyst Reports for Alphabet, Berkshire Hathaway & Nike
Jun 27 / Zacks.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
Jun 22 / Zacks.com - Paid Partner Content
Vaccine Small-Cap Just Took a Big Step Forward
Jun 26 / GuruFocus News - Paid Partner Content
VBI Vaccines Just Took a Major Step Forward in Its HBV Program
Jun 21 / GuruFocus News - Paid Partner Content
Novartis Cardiovascular Drug Positive, NSCLC Drug Approved
Jun 26 / Zacks.com - Paid Partner Content
Novartis (NVS) Biosimilar of MabThera Approved in the EU
Jun 19 / Zacks.com - Paid Partner Content
Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead G...
Jun 26 / TheStreet.com - Paid Partner Content
GlaxoSmithKline's Benlysta Positive in Continuation Trial
Jun 19 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
Should Value Investors Pick GlaxoSmithKline (GSK) Stock Now?
Jun 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.07
Today’s open44.04
Day’s range43.87 - 44.10
Volume1,992,222
Average volume (3 months)2,982,104
Market cap$108.4B
Dividend yield4.53%
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.52%
Earnings growth (next 5 years)+5.55%
Revenue growth (last year)+2.85%
P/E ratio64.4
Price/Sales2.52
Price/Book77.22

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-3.00-2.24%
ABBVAbbVie-0.35-0.48%
BMYBristol-Myers Squibb-1.02-1.79%
LLYEli Lilly and Co-1.24-1.47%
Data as of 06/27/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts